Viewing Study NCT00401635


Ignite Creation Date: 2025-12-24 @ 10:07 PM
Ignite Modification Date: 2025-12-28 @ 7:07 AM
Study NCT ID: NCT00401635
Status: COMPLETED
Last Update Posted: 2007-09-05
First Post: 2006-11-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin
Sponsor: National Cancer Institute, Naples
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module